期刊文献+

糖尿病心肌病外周血单核细胞Toll样受体4、肿瘤坏死因子-α的表达及其与心肌灌注的相关性 被引量:6

Expression of Toll-like receptor 4 and tumor necrosis factor-α on peripheral-blood mononuclear cells and their correlation with myocardial perfusion in patients with diabetic cardiomyopathy
原文传递
导出
摘要 目的 探讨糖尿病心肌病患者外周血单核细胞 Toll 样受体4(TLR4)、肿瘤坏死因子-α(TNF-α)的表达及其与心肌灌注的相关性,初步探讨 TLR4、TNF-α在糖尿病心肌病心肌灌注中的作用,为临床诊治糖尿病心肌病提供新的思路.方法 2型糖尿病(T2-DM)组37例(其中糖尿病心肌病组17例、单纯T2-DM组20例)健康对照组20例.采用SYBR GreenⅠ实时荧光定量RT-PCR检测外周血单核细胞(PBMC)TLR4及TNF-α的mRNA表达.流式细胞仪及ELISA法分别检测单核细胞分泌TLR4、TNF-α蛋白水平.进行心肌灌注单电子发射计算机体层扫描(SPECT)图像可视化分析.结果 糖尿病心肌病组单核细胞TLR4和TNF-α的 mRNA及蛋白表达均显著高于单纯T2-DM组,单纯T2-DM组高于对照组(P均〈0.05).糖尿病心肌病组心肌灌注总负荷评分(SSS评分) 和总静息评分(SRS评分)显著高于单纯T2-DM组,单纯T2-DM组高于对照组(P均〈0.01).外周血单核细胞TLR4和TNF-α表达与SSS评分水平呈正相关(r=0.75,P〈0.05;r=0.931,P〈0.005),与SRS评分水平也呈正相关(r=0.78,P〈0.05;r=0.89,P〈0.005).DCM组SSS评分、SRS评分与可溶性血管细胞黏附分子呈正相关(r=0.728,P〈0.005;r=0.738,P〈0.005),与B型利钠肽、左心室射血分数、二尖瓣口舒张早期峰值速度/舒张晚期峰值速度、糖化血红蛋白、空腹血糖、空腹胰岛素、低密度脂蛋白胆固醇无相关性(P均〉0.05).结论 研究提示TLR4、TNF-α可能在糖尿病心肌病心肌灌注中具有炎症损伤的作用,其机制可能是通过上调 TLR4、TNF-α表达介导级联反应,从而促进内皮分泌可溶性血管细胞黏附分子-1引起心肌灌注的炎症损伤. Objective To explore the expression of Toll-like receptor 4(TLR4) and tumor necrosis factor-α (TNF-α) on peripheral-blood mononuclear cells(PBMCs) and their correlation with myocardial perfusion in patients with diabetic cardiomyopathy (DCM).Methods The expression of TLR4 and TNF-α mRNA on PBMCs were examined by SYBR GreenⅠreal-time quantitative reverse transcription ploymerse chain reaction (RT-PCR), the levels of TLR4 and TNF-α were examined by flow cytometric analysis and enzyme-linked immuno sorbent assay (ELISA) on DCM group (n=20) , Type 2 diabetic group (n=22) and control group (n=20). Myocardial perfusion was visualized by single-photon emission computed tomography (SPECT). Results The expressions of TLR4 and TNF-α mRNA/protein on PBMCs in DCM group were significantly higher than in Type 2 diabetic group, and higher in Type 2 diabetic group than in control groups(P〈0.05); summed stress score (SSS)and summed rest score (SRS) of myocardial perfusion in DCM group were significantly higher than in Type 2 diabetic group, and higher in Type 2 diabetic group than in control groups(P〈0.01).The expression of TLR4, TNF-α was positively correlated with SSS (r=0.75,P〈0.05;r=0.931,P〈0.005) and SRS(r=0.78,P〈0.005; r=0.789,P〈0.005). SSS and SRS in DCM group were also positively correlated with soluble vascular cell adhesion molecule-1 (sVCAM-1) (r=0.728,P〈0.005; r=0.738,P〈0.005) but there was no correlation between SSS and SRS and brain natriuretic peptide, LVEF, E/A, HbA1c, FBG, FIN and LDL-C (P〉0.05).Conclusion The increased expression of TLR4 and TNF-α mRNA/protein on PBMCs and increased serum sVCAM-1 is linked with reduced myocardial perfusion in DCM group. TLR4 and TNF-α may thus play a critical role in the myocardial perfusion inflammation injury in these patients.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2011年第6期503-507,共5页 Chinese Journal of Cardiology
关键词 糖尿病 心肌疾病 TOLL 样受体4 肿瘤坏死因子α 心肌灌注 Diabetes mellitus Cardiomyopathies Toll-like receptor 4 Tumor necrosis factor-alpha Myocardial perfusion
  • 相关文献

参考文献15

  • 1Rubler S, Dlugash J, Yuceoglu YZ, et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol, 1972,30:595-602.
  • 2Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. JAMA, 1974,229 : 1749-1754.
  • 3Poornima IG, Parikh P, Shannon RP, et al. Diabetic cardiomyopathy:the search for a unifying hypothesis. Circ Res, 2006,98 : 596-605.
  • 4Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation, 2007,115 : 3213-3223.
  • 5钱宗薇 刘新民.糖尿病心肌病,实用内分泌学[M].北京:人民军医出版社,1997.332-333.
  • 6Livak K, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 ( -Delta Delta C (T) ) Method. Methods ,2001,25:402-408.
  • 7Nichols K, Lefkowitz D, Faber T, et al. Echocardiographic validation of gated SPECT ventricular function measurements. J Nucl Med ,2000,41 : 1308-1314.
  • 8Devaraj S, Dasu MR, Rockwood J, et al. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes : further evidence of a proinflammatory state. J Clin Endocrinol Metab,2008, 93 : 578-583.
  • 9Boone DL, Turer EE, Lee EG, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immuno1,2004,5 : 1052-1060.
  • 10Huittinen T, Leinonen M, Tenkanen L, et al. Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioseler Thromb Vase Bio1,2002 ,22 :431-437.

共引文献1

同被引文献60

  • 1Andrea Picchi,Stefano Capobianco,Marta Focardi.Coronary microvascular dysfunction in diabetes mellitus:A review[J].World Journal of Cardiology,2010,2(11):377-390. 被引量:24
  • 2李志强,郑兴.炎症与冠心病[J].中国心血管病研究,2006,4(3):233-235. 被引量:38
  • 3De Luca G, Gibson CM, Bellandi F, etal. Diabetes mellitus is associ ated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial in farction treated with primary angioplasty and glycoprotein llb-Illa in hlhitar fl] 4th,roelra+is. 2009. 207 (1) : 181-185.
  • 4Silber S, Albertsson P, Avils FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary In terventions of the European Society of Cardiology [J] . Eur Heart J,2005, 26 (8) : 804-847.
  • 5Burzotta F, Trani C, Romagnoli E, et o/. A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with throm- bus-containing lesions: the Diver C.E. study [J] . Catheter Cardiovasc lnterv, 2006, 67 (6) : 887-893.
  • 6Gibson CM, Schomig A. Coronary and myocardial angiography: anglo graphic assessment of both epicardial and myocardial perfusion [J] . Circulation, 2004, 109 (25) : 3096-3105.
  • 7Ishihara M, Kojima S, Sakamoto T, et aL Acute hyperglycemia is as- sociated with adverse outcome after acute myocardial infarction in the coronary intervention era [J] . Am Heart J, 2005, 150 (4) : 814-820.
  • 8Takahashi A, Sakamoto S, Taniguehi N. Thrombus aspiration with mi- crocatheter for distal embolization during primary angioplasty for acute myocardial infarction: technical notes [J] . J Invasive Cardiol, 2012, 24 (11) :618-621.
  • 9De Carlo M, Aquaro GD, Palmieri C, eta/. A prospective randomized trial of thrombectomy versus no thrombectomy in patients with ST-seg ment elevation myocardial infarction and thrombus-rich lesions: MUSTELA (MUltidevice Thrombectomy in Acute ST-Segment ELeva- tion Acute Myocardial Infarction) trial [J] . JA CC Cardiovasc Interv, 2012, 5 (12) : I223-1230.
  • 10Limbruno U, De Carlo M, Pistolesi S, et al. Distal embolization during primary angioplasty: histopathologic features and predictability [J] . Ani Heart J, 2005, 150 (1) : 102-108.

引证文献6

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部